89bio (ETNB) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ETNB Stock Alerts $8.24 -0.34 (-3.96%) (As of 02:28 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBofA raises 89bio to stock buy amid MASH outlookinvesting.com - April 24 at 5:32 PM89bio (NASDAQ:ETNB) Receives "Buy" Rating from Bank of Americaamericanbankingnews.com - April 23 at 3:50 AM89bio, Inc. (ETNB) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - April 22 at 1:42 PM89bio (NASDAQ:ETNB) Shares Gap Up to $9.08marketbeat.com - April 22 at 12:49 PMBank of America Reaffirms "Buy" Rating for 89bio (NASDAQ:ETNB)marketbeat.com - April 22 at 8:35 AMFederated Hermes Inc. Sells 167,035 Shares of 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - April 22 at 5:56 AMReviewing 89bio (NASDAQ:ETNB) & 2seventy bio (NASDAQ:TSVT)americanbankingnews.com - April 22 at 1:12 AM89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directorsglobenewswire.com - April 17 at 4:05 PM89bio (NASDAQ:ETNB) Stock Price Down 4.2%marketbeat.com - April 11 at 4:01 PMVanguard Group Inc. Increases Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - April 9 at 4:08 AM89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 5 at 4:05 PM89bio (NASDAQ:ETNB) Earns Overweight Rating from Cantor Fitzgeraldmarketbeat.com - April 5 at 10:27 AM89bio Inc CEO Rohan Palekar Sells 52,718 Sharesfinance.yahoo.com - April 3 at 9:14 PM89bio (NASDAQ:ETNB) Shares Down 6.8% marketbeat.com - April 1 at 3:29 PM89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - April 1 at 4:30 AMBuy Rating Affirmed for 89bio’s Pegozafermin: A Promising NASH Treatment with Strong Regulatory Endorsementsmarkets.businessinsider.com - March 29 at 7:21 AMAnalysts Are Bullish on These Healthcare Stocks: 89bio (ETNB), Perspective Therapeutics (CATX)markets.businessinsider.com - March 27 at 8:55 PM89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosisglobenewswire.com - March 27 at 8:00 AM89bio (NASDAQ:ETNB) Trading Down 4.3%marketbeat.com - March 20 at 12:46 PM89bio, Inc. (NASDAQ:ETNB) Director Buys $20,722,500.00 in Stockinsidertrades.com - March 16 at 7:50 AMETNB Apr 2024 12.500 putfinance.yahoo.com - March 16 at 7:44 AM89bio (NASDAQ:ETNB) Trading Up 3.3%marketbeat.com - March 15 at 12:38 PMAnalysts Are Bullish on These Healthcare Stocks: 89bio (ETNB), Intuitive Surgical (ISRG)markets.businessinsider.com - March 15 at 9:30 AM89bio (NASDAQ:ETNB) Stock Price Down 7.5%marketbeat.com - March 14 at 1:23 PM89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosisglobenewswire.com - March 12 at 8:00 AMBuffett Loads Up on This Stock Again, Plus CEO Insider Buying247wallst.com - March 10 at 9:50 AM89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 8 at 4:05 PMInsider Trading: Director Boosts Stake in 89bio (NASDAQ:ETNB) Stockmsn.com - March 7 at 5:46 PM89bio (NASDAQ:ETNB) Trading 8.4% Higher on Insider Buying Activitymarketbeat.com - March 7 at 10:31 AMAdage Capital Partners GP L.L.C. Grows Stock Position in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - March 7 at 7:44 AMFY2024 Earnings Forecast for 89bio, Inc. (NASDAQ:ETNB) Issued By Cantor Fitzgeraldmarketbeat.com - March 7 at 7:37 AMBuy Rating Reaffirmed for 89bio with Potential Market Edge in Fibrosis and Metabolic Diseasesmarkets.businessinsider.com - March 7 at 7:35 AM89bio, Inc. (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - March 7 at 3:52 AM89bio price target raised by $8 at Evercore ISI, here's whyrealmoney.thestreet.com - March 6 at 10:44 PMDeutsche Bank AG Has $503,000 Position in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - March 6 at 4:36 AM89bio to Participate in the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 5 at 4:05 PM89bio (NASDAQ:ETNB) Trading Down 6.8%marketbeat.com - March 5 at 2:52 PM89bio Inc.wsj.com - March 5 at 12:43 PM89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Oppenheimermarketbeat.com - March 5 at 8:18 AMETNB Mar 2024 20.000 putfinance.yahoo.com - March 5 at 2:41 AMETNB Mar 2024 20.000 callfinance.yahoo.com - March 5 at 2:41 AMCantor Fitzgerald Reaffirms "Overweight" Rating for 89bio (NASDAQ:ETNB)marketbeat.com - March 4 at 10:25 AMCharles Schwab Investment Management Inc. Purchases 322,339 Shares of 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - March 3 at 4:20 AM89bio Inc (ETNB) Reports Increased R&D Spend and Strengthened Cash Position in Q4 and Full ...finance.yahoo.com - March 2 at 5:28 AM89bio (NASDAQ:ETNB) Issues Earnings Resultsmarketbeat.com - March 1 at 1:57 PM89bio (NASDAQ:ETNB) Trading 7.2% Higher marketbeat.com - March 1 at 12:14 PM89bio (NASDAQ:ETNB) PT Lowered to $14.00 at Royal Bank of Canadamarketbeat.com - March 1 at 10:43 AMBraidwell LP Acquires New Holdings in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - March 1 at 10:18 AM89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updatesglobenewswire.com - February 29 at 4:05 PMAlgert Global LLC Sells 105,005 Shares of 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - February 29 at 6:33 AM Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… ETNB Media Mentions By Week ETNB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.430.42▲Average Medical News Sentiment ETNB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼83▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ARS Pharmaceuticals News OPKO Health News Cassava Sciences News Zentalis Pharmaceuticals News Innoviva News ABIVAX Société Anonyme News Sage Therapeutics News Arcturus Therapeutics News Pliant Therapeutics News Intercept Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
